SCHEMBL8974235

SCHEMBL8974235

NS(=O)(=O)c1ccc(C2=CC(CO)C=C2c2ccc(F)nc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.45
VRK2 Q86Y07 1/20 0.39
DRD1 P21728 1/20 0.39
PTGS1 P23219 4/20 0.38
CA2 P00918 6/20 0.38
CA9 Q16790 6/20 0.38
CA1 P00915 4/20 0.38
CA4 P22748 3/20 0.38
CA5A P35218 3/20 0.38
CA5B Q9Y2D0 3/20 0.38
CA12 O43570 4/20 0.38
TDO2 P48775 1/20 0.37
MAP2K7 O14733 1/20 0.37
MAP2K4 P45985 1/20 0.37
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36
CA6 P23280 1/20 0.36
CA7 P43166 1/20 0.36
CA14 Q9ULX7 1/20 0.36
MAOA P21397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974514 0.88 PTGS2 (0.40) PTGS2VRK2DRD1PTGS1CA2
SCHEMBL8973845 0.87 PTGS2 (0.42) PTGS2VRK2DRD1PTGS1CA2
SCHEMBL8974523 0.86 KIF11 (0.42) PTGS2DRD1PTGS1CA2CA9
SCHEMBL8974438 0.84 PTGS2 (0.43) PTGS2VRK2PTGS1CA2CA9
SCHEMBL8973747 0.84 PTGS2 (0.55) PTGS2DRD1PTGS1CA2CA9
SCHEMBL8974387 0.83 PTGS2 (0.45) PTGS2VRK2PTGS1CA2CA9
SCHEMBL8974620 0.82 PTGS2 (0.42) PTGS2VRK2PTGS1CA2CA9
SCHEMBL8974301 0.81 PTGS2 (0.43) PTGS2DRD1PTGS1CA2CA9
SCHEMBL8974502 0.81 KIF11 (0.41) PTGS2VRK2PTGS1CA2CA9
SCHEMBL8973866 0.80 PTGS2 (0.48) PTGS2VRK2DRD1PTGS1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed